ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000706.1|Kanamycin_1 # 2 # 268 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0000706.1|Kanamycin_1 	2	268	+	Loose	500	103.99	sgm	51.76	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GATCCCGAACCGGCCGACGTCACCTTCCTGTTCAAGGCCGTCCCCTGCCTTGAGGCACAGGGCAAGGGCCTCGGCTGGAAGCTGCTCGACCAGATCAATTCCCCCGTCCTGGTGGTGAGTTTCCCCACCAAGACCCTGGGCCGCCGCTCCAGGGGCATGTACCAGACCCATTCCGCGGAATTCGCCCGGCGCGTCGCCGAACGGCCCTGGAAGTGCGACGAGATCGAGTTCGGCGACGAACTCGTCTACGTGGTCACGAAGGGCTGA	DPEPADVTFLFKAVPCLEAQGKGLGWKLLDQINSPVLVVSFPTKTLGRRSRGMYQTHSAEFARRVAERPWKCDEIEFGDELVYVVTKG	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	32.12	gnl|BL_ORD_ID|1906|hsp_num:0	2079			567	822	dibekacin; amikacin; gentamicin C; sisomicin; netilmicin; kanamycin A; tobramycin; isepamicin; G418; arbekacin; gentamicin B; gentamicin
BGC0000706.1|Kanamycin_2 # 351 # 1595 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.721	BGC0000706.1|Kanamycin_2 	351	1595	+	Loose	700	47.3654	LpsB	24.66	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGCGTACTCCGGCTCACCCCGTTCTACCACCACGACTGTGTGGACAGCTGGCCCGCCGAGTTCGACGCGGTGGGCGGCATGCAGGTACAGATCCTGCGGATGTCCCGCGCCCTGGCCGAGTTGGGGGTGCGCCAGCAGGTGCTCACCGTCGGCTTCCCCGGTCTGCCCAGAGTGCGGCGCGACTCCGAGAACCTGGTGGTGCGGATCACCAGGGCCCCGCTGCCCAGGCTGCGCTCCAGGATCACCGGCCTGGTCGGCCTCAACCAGGCGTGGCTGGCCGCCGCGCTCACCGAATGCGTGAAACTGCGGCGCCGCTGGCCCGCCGACCTGATCCAGGTCCATCTGGACGGCCAGCTCTGGGCGTTGCTCGCGGGACCGGTCGCCGCCCGCCTGGTGGGCGTGCCGTACACGGTCACCGTGCACTGCTCGCGGCTGGCGGTGTATCAGCCCATGTCCACCGTCGACCGCATCCAGCACCCCTTGGTGACCGCCGTCGAGCGCTGGGCGCTGCGCCGTGCGGCCGGGATCACCACGCTGACCGAGCGGACCGCCACGGTGCTCGCCGCCGAACTGGGCGCGGCCCAGAGGGTGATCGACGTGGTGCCCGACGCGGTCGACCCCGATCGGGCCGAGGCCGCGCCCGCCGAGGTCGAGCGGCTGAAGAAGCGTTTCGGCCTGCCGCAGGAGGGCGGTCCCGTCATCGGATTCGTCGGCCGGATCGCCCACGAGAAGGGCTGGCGCCACGCCGTCCAGGCGGTGGCCGAACTCGCGGACGCGGGCCGGGACTTCACCTTCCTCGTCGTCGGAGACGGACCGCAGCGGGCCGACATGGAGGCGGCGGTGGCCGAGGCCGGTCTCACCGACCGGTTCGTCTTCACCGGGTTCCTGCCCAACGACGAGATCCCCGCCGTGATGACCGCCCTGGACGTCCTCCTGATGCCGTCCGTGCACGAGGAGTTGGGCGGCAGCGCCGTCGAGGCCATGCTCGCGGGAACGCCGGTGGCCGCCTACGGGGTCGGCGGCCTGTGCGACACCGTGGGCAAGGTGACCCCGTCCTTGCTGGCCGCGCCCGGCCAGGTGGCCGAACTCGCGCGGACGGTCAAGCGGGTACTCGACGATCCCGCGCCGGTCCTGGCCGAATTGCGTGCCGGACGGGAGTGGCTCGCGGACGAGTTCGGTGTCCACCACGCGGCCGGTCTCGCGTTGGCCCACTATGAGCGGGTACTCGGCAAAGAACGGTAG	MRVLRLTPFYHHDCVDSWPAEFDAVGGMQVQILRMSRALAELGVRQQVLTVGFPGLPRVRRDSENLVVRITRAPLPRLRSRITGLVGLNQAWLAAALTECVKLRRRWPADLIQVHLDGQLWALLAGPVAARLVGVPYTVTVHCSRLAVYQPMSTVDRIQHPLVTAVERWALRRAAGITTLTERTATVLAAELGAAQRVIDVVPDAVDPDRAEAAPAEVERLKKRFGLPQEGGPVIGFVGRIAHEKGWRHAVQAVAELADAGRDFTFLVVGDGPQRADMEAAVAEAGLTDRFVFTGFLPNDEIPAVMTALDVLLMPSVHEELGGSAVEAMLAGTPVAAYGVGGLCDTVGKVTPSLLAAPGQVAELARTVKRVLDDPAPVLAELRAGREWLADEFGVHHAAGLALAHYERVLGKER	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.11	gnl|BL_ORD_ID|2781|hsp_num:0	3793			594	1026	colistin A; colistin B; defensin
BGC0000706.1|Kanamycin_3 # 1654 # 2661 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0000706.1|Kanamycin_3 	1654	2661	+	Loose	1050	31.9574	lmrC	33.04	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGAGGCAGGACTGGCAGCACTTGGACGAGTCCGACGTACGGGTCCGACCGGGACGGCGTAGTTCCCGCCCGCGCAGCAAGAACCGCCCCGAGCACGCCGACGCCCGGTCCGCCATGGTGGTCGGGGTCGATCGCGGCCGGTGGACCTGCGTCCTGGACTCCGACCCCGAGAGCCGGATCACCGCGATGCGCGCCCGCGAACTGGGCCGCAAGTCGGCGGTGATAGGCGACCGCGTCGACGTGATCGGCGACCTGTCCGGCAAGCCGGGCACCCTGGCCCGCATGGTCCGGGTCGCCCGGCGCGACAGCGTCCTGCGGCGCACCGCCGACGACACGGACCCCTACGAGCGGGTGGTGGTCGCCAACGCGGAACAGCTGGTGATCGTCTGCGCGTTGGCGGCGCCGCAGCCGCGCGCCGGTTTCATCGACCGTGCCCTGGTGGCGGCCTACGCGGGCGGTCTGCGGCCGGTGCTCTGCCTGACCAAGGCGGACCTGAAGGGCCCCGAGGACGTGGTGAGCACCTACGCCCATCTGGATCTGTCGATCGTGGTCACGCGCTCCGACCGCGCCCCGGACGCCCTGCGCGAGCAGCTGGCCGGGCGCGTCTCGGCCCTGGTCGGACACTCCGGAGTCGGCAAGTCCACGCTGATCAACATCCTGATCCCGCAGGCCCGGCGGGTCACCGGTGAAGTGAGCGCGATCGGGAAGGGCCGCCACACGTCCACCTCGGCCGTCGCCCTGCCGCTGCCGGACGGCGGCTGGGCCGTGGACACCCCCGGCATCCGCTCCTTCGGGCTTGCCCACGTCACGTCCGACGACGTCCTCGACGCCTTCCCCGACCTGAGCGACGGCGCGGAGGACTGCCCGTCCGGCTGCCGTCATCTGGGCGCCCCGCACGACTCGGGATGCGGCCTGGAGCGCCTGAGCGAAGCCGATCCGGCCAGGGCGCGGCGGCTGGAGTCGCTGCGCCGCCTGCTGCGCTCGCACGCGGGCATCGAAGAGGAGTGA	MRQDWQHLDESDVRVRPGRRSSRPRSKNRPEHADARSAMVVGVDRGRWTCVLDSDPESRITAMRARELGRKSAVIGDRVDVIGDLSGKPGTLARMVRVARRDSVLRRTADDTDPYERVVVANAEQLVIVCALAAPQPRAGFIDRALVAAYAGGLRPVLCLTKADLKGPEDVVSTYAHLDLSIVVTRSDRAPDALREQLAGRVSALVGHSGVGKSTLINILIPQARRVTGEVSAIGKGRHTSTSAVALPLPDGGWAVDTPGIRSFGLAHVTSDDVLDAFPDLSDGAEDCPSGCRHLGAPHDSGCGLERLSEADPARARRLESLRRLLRSHAGIEEE	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	60.91	gnl|BL_ORD_ID|900|hsp_num:0	974			6	339	lincomycin; clindamycin; celesticetin
BGC0000706.1|Kanamycin_4 # 2696 # 3094 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000706.1|Kanamycin_4 	2696	3094	+	Loose	750	25.7942	tet(50)	26.19	3004584	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCCGACTGACCCACATCAGCGCCCCCGAGGGCGTCGCCCCCGCCACCGCCTACACCCACGTCGTGATGGGCACGGGCCGATTCGTCGCGATATCCGGCCAGTTGGCCCTGGACGAGGACGGCAAGCTGGTCGGCGAGGGCGACGCGGCGGCGCAGGCCCACCAGGTCTTCGAGAACCTGCGGCGCTGCCTGACCGCGGCGGGCGCGACGTTCGACGACGTCGTGAAGCTGACGTACTTCGTGACGGACATGGCGCACATGCGGGCGATCCGCGGCGCGCGGGACGCCTTCCTTGACCCCGAGCGGCTGCCCGCTTCCTCGGCGGTGCAGGTGGGCGCGCTGGTCGCGCCCGAGTATCTGATGGAGATCGAGGCGTTCGCGGTGGTGGCCGAGTAG	MSRLTHISAPEGVAPATAYTHVVMGTGRFVAISGQLALDEDGKLVGEGDAAAQAHQVFENLRRCLTAAGATFDDVVKLTYFVTDMAHMRAIRGARDAFLDPERLPASSAVQVGALVAPEYLMEIEAFAVVAE	MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE	34.02	gnl|BL_ORD_ID|2722|hsp_num:0	3287			156	282	tetracycline; oxytetracycline
BGC0000706.1|Kanamycin_5 # 3118 # 3687 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.767	BGC0000706.1|Kanamycin_5 	3118	3687	-	Loose	500	25.7942	chrB	48.48	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGATGAGGAGTTGCGGACGGTGACGGAACGTTTACGCGCCGAGGCGGGGGGCTCGAAGGAGTACGAGCGGCTGGTCGCGACCGGTGACCTCGAGGAGCTCGCCGAGGTGCTCGTCTCGCCGGGACAGCCCTTGTGGACAAGGGAGTTGGCGGCGGTCCTGCTCGGCGTCGCCGGGGACCGCCGGGCCTTCGAATCGCTCGTCCTGCTCCTCAACCACCGGGACGCGCCGCGCTGCGCGGCGGCGGCGTACGCCCTGGCCAGGCTCGGCGACCCCCGCACCGCGCGCGCGGCGGCCGCCCTGGCGACGAACGAACTCCGCGTCGCCTACGCCCTGCACCCGGTGCGCCTCCTGACGGAGCTGCGCGCCCCGGAGTCGGCGCCCGCGCTGATCACGACGCTGCGGCGGCGCCTCGCCCCGCACGACCCGTTCGGCAAGATCGCGCTCGCCTGTGTGGAGGGCCTGGGCGCGCTCGGGGACCCCCGGGCGAGACCGGTGCTGACCGCGGCGCGGGCCCATCCCCGCCTCGCGGCGGCGGCCTCGGCGGCCCTGGCGCGGCTGCCGGAGTGA	MDEELRTVTERLRAEAGGSKEYERLVATGDLEELAEVLVSPGQPLWTRELAAVLLGVAGDRRAFESLVLLLNHRDAPRCAAAAYALARLGDPRTARAAAALATNELRVAYALHPVRLLTELRAPESAPALITTLRRRLAPHDPFGKIALACVEGLGALGDPRARPVLTAARAHPRLAAAASAALARLPE	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	67.50	gnl|BL_ORD_ID|274|hsp_num:0	305			345	444	tylosin; chalcomycin; mycinamicin
BGC0000706.1|Kanamycin_7 # 5810 # 6745 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000706.1|Kanamycin_7 	5810	6745	+	Loose	400	46.2098	cmeR	35.38	3000526	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGGCGCTGAGCCGGCCGAGGACCGCCTGGACTCCGCGACGGACTGGGGCGGGCTGCTCGAACCCTCGGGCGGCCCTCTCCCACACGAGCACCGTGCTGCGCATATGCAGTACGTTCGTGGCATGTCCAAGGCCGCCAAGTCCTCACGCAACGCCAGCCCCGACGCTCCGGAGAGCGCCGCGGGCAGCCGTGCCGCCGCCCAACGCCTCAAGATGCGCAGGGAGCTGGCTGCGGCGGCCATGGAGCTCTTCGCGACCAAGGGGTACGAGGCGACGACGGTCGACGAGATCGCCGCCGCCGCGGGCGTCGCCCGCCGGACCTTCTTCCGGCACTTCCGCTCCAAGGAAGAGGCGATCTTCCCCGACCACGACGACACCCTGGTCCGCGCGGAGGAGGTGCTGAACGCCGCACCGGCGCACGAGCACCCGCTCGACACGGTGTGCCGCGGCATCAAGGAAGTCATGAAGATGTACGCGGCCTCGCCCGCGGTCTCCGTGGAGCGCTACCGGCTGACCCGTGAGGTGCCCACGCTGCGCGAGCGCGAGATCGCCTCCGTGGCCCGCTACGAACGGCTGTTCACGCGGTATCTGCTCGGCCACTTCGATGAGCAGGCGCACCACGACGGCAACGACGACCCGCTGCTCGCCGAGGTCGCCGCCTCCGCGGTGGTCACCGCCCACAACCACGTCCTGCGCCGCTGGCTGCGGGCGGGCGGCCAGGGCGACCTGGAGGCCCACCTGAACCACGCGTTCGGCATCGTCCGGCTCACCTTCGGCACCGGGATCGGCGCGGGCCGCTCCTCGGCACCGGCCACCGCCCCCGCCACGGTCTCCGCGCAGGGCGAGGTCCTGGTCACCGTGGCCCGTACGGACGCGCCGCTCGACGAGGTCATGCGGACGATCGAGAAAGCCCTCCGCGAGCGGGCCTCATAG	MPGAEPAEDRLDSATDWGGLLEPSGGPLPHEHRAAHMQYVRGMSKAAKSSRNASPDAPESAAGSRAAAQRLKMRRELAAAAMELFATKGYEATTVDEIAAAAGVARRTFFRHFRSKEEAIFPDHDDTLVRAEEVLNAAPAHEHPLDTVCRGIKEVMKMYAASPAVSVERYRLTREVPTLREREIASVARYERLFTRYLLGHFDEQAHHDGNDDPLLAEVAASAVVTAHNHVLRRWLRAGGQGDLEAHLNHAFGIVRLTFGTGIGAGRSSAPATAPATVSAQGEVLVTVARTDAPLDEVMRTIEKALRERAS	MNSNRTPSQKVLARQEKIKAVALELFLTKGYQETSLSDIIKLSGGSYSNIYDGFKSKEGLFFEILDDICKKHFHLIYSKTQEIENGTLKEILTSFGLAFIEIFNQPEAVAFGKIIYSQVYDKDRHLANWIENNQQNFSYNILMGFFKQQNNSYMKKNAEKLAVLFCTMLKEPYHHLNVLINAPLKNKKEQKEHVEFVVNVFLNGINSSKA	148.10	gnl|BL_ORD_ID|1131|hsp_num:0	1232			9	204	erythromycin; cefotaxime; fusidic acid
BGC0000706.1|Kanamycin_8 # 7143 # 8480 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.679	BGC0000706.1|Kanamycin_8 	7143	8480	+	Loose	660	41.2022	MexS	23.89	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATCCTGGACGCGATTCAGTCGCAGGACGCACAGTCCGCCGACTTCGCCGCTCTCCCCCTGCCCGACTCGTACCGCGCGATCACCGTGCACAAGGACGAGACGGAGATGTTCGCGGGCCTGGACACCCGCGACAAGGACCCCCGCAAGTCCCTCCACCTGGACGACGTGCCGGTGCCCGAACTCGGCCCCGGTGAAGCCCTGGTGGCCGTGATGGCCTCCTCGGTGAACTACAACTCCGTGTGGACCTCGATCTTCGAGCCGCTGTCGACCTTCGGCTTCCTGGAGCGCTACGGCAAGGTCAGCGAGCTCACCAAGCGCCACGACCTGCCGTACCACGTCATCGGCTCCGACCTGGCGGGCGTCGTGCTGCGCACCGGGCCCGGCGTGAACTCCTGGAAGCCGGGCGACGAGGTCGTCGCGCACTGCCTGAGCGTCGAGTTGGAGTCGAGCGACGGCCACAACGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACGAACTTCGGCGGCCTCGCCGAGATCGCGCTCGTCAAGTCCAACCAGCTCATGCCCAAGCCGGGCCACCTGAGTTGGGAGGAGGCCGCCGCTCCCGGGCTCGTGAACTCCACCGCGTACCGCCAGCTCGTCTCGCGCAACGGCGCCGACATGAAGCAGGGCGACAACGTGCTGATCTGGGGCGCGAGCGGCGGACTCGGCTCCTACGCCACGCAGTTCGCGCTCGCCGGCGGCGCCAACCCGATCTGTGTGGTCTCCAGCGAGCAGAAGGCCGACATCTGCCGCTCCATGGGCGCCGAGGCGATCATCGACCGCAGCGCCGAGGGCTACCGGTTCTGGAAGGACGAGCGCACCCAGGACCCCAAGGAGTGGAAGCGCTTCGGCAAGCGCATCCGCGAGTTCACCGGCGGCGAGGACATCGACATCGTCTTCGAGCACCCCGGCCGCGAGACCTTCGGCGCCAGCGTCTACGTCACCCGCAAGGGCGGCACCATCACCACCTGCGCCTCCACCTCGGGCTACATGCACGAGTACGACAACCGCTACCTGTGGATGTCCCTCAAGCGCATCATCGGCTCCCACTTCGCCAACTACCGCGAGGCCTGGGAGGCCAACCGCCTGATCGCCAAGGGCAAGATCCACCCCACCCTCTCCAAGGTCTACTCCCTCGAAGAGACAGGCCAGGCGGCCCACGACGTCCACCGCAACGCCCACCAGGGCAAGGTCGGCGTGCTCGCCCTCGCGCCCAAGGAGGGCCTGGGCGTGCGCGACCCGGAGCTGCGGGCCCAGCACATCGACGCCATCAACCGTTTCCGCAACGTCTGA	VKEILDAIQSQDAQSADFAALPLPDSYRAITVHKDETEMFAGLDTRDKDPRKSLHLDDVPVPELGPGEALVAVMASSVNYNSVWTSIFEPLSTFGFLERYGKVSELTKRHDLPYHVIGSDLAGVVLRTGPGVNSWKPGDEVVAHCLSVELESSDGHNDTMLDPEQRIWGFETNFGGLAEIALVKSNQLMPKPGHLSWEEAAAPGLVNSTAYRQLVSRNGADMKQGDNVLIWGASGGLGSYATQFALAGGANPICVVSSEQKADICRSMGAEAIIDRSAEGYRFWKDERTQDPKEWKRFGKRIREFTGGEDIDIVFEHPGRETFGASVYVTRKGGTITTCASTSGYMHEYDNRYLWMSLKRIIGSHFANYREAWEANRLIAKGKIHPTLSKVYSLEETGQAAHDVHRNAHQGKVGVLALAPKEGLGVRDPELRAQHIDAINRFRNV	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	131.27	gnl|BL_ORD_ID|1039|hsp_num:0	1041			33	735	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000706.1|Kanamycin_9 # 8503 # 10551 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.691	BGC0000706.1|Kanamycin_9 	8503	10551	+	Loose	500	28.4906	OXA-603	36.36	3005824	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACAGAGCGTCAGAAGGACCGGCCGTGGCTCATGCGGACGTACGCCGGTCACTCCACGGCGGAGGCGTCCAACGAGCTGTACCGGCGCAACCTCGCCAAGGGGCAGACGGGCCTCTCGGTCGCGTTCGACCTGCCCACGCAGACCGGCTACGACCCCGACCACATCCTCGCCCGCGGCGAGGTCGGCCGGGTCGGCGTCCCGGTCTCGCACCTGGGTGACATGCGGCGGCTGTTCCAGGACATCCCCCTGGACCGGATGAACACCTCGATGACGATCAACGCCACCGCCATGTGGCTTCTGGCGCTCTATCAGGTGGTCGCGGAGGAGCAGGGCGCGGACATCACCCAGCTCCAGGGGACGACGCAGAACGACATCGTCAAGGAGTACCTCTCGCGCGGGACGCACGTCTTCCCGCCGGGCCCCTCCCTGCGGCTGACCACCGACATGATCACGTACACGGTGGCCCACATCCCCAAGTGGAACCCGATCAACATCTGCAGCTACCACCTCCAGGAGGCGGGGGCCACACCGGTCCAGGAGATCGCGTACGCGATGTCCACCGCCATCGCGGTCCTCGATGCCGTACGCGACTCCGGGCAGGTCCCCGAGGAGAAGTTCGGGGACGTCGTGGCCCGCATCTCCTTCTTCGTGAACGCGGGCGTCCGCTTCATCGAGGAGATGTGCAAGATGCGGGCGTTCGGGCGGATCTGGGACCAGATCACGCGCGAGCGGTACGGCATCGAGAACCCGAAGCAGCGCCGGTTCCGCTACGGCGTGCAGGTCAACTCCCTGGGCCTGACCGAGGCCCAGCCGGAGAACAACGTCCAGCGGATCGTGCTCGAAATGCTGGCCGTCACCCTCTCCAAGGACGCACGCGCGCGTGCCGTGCAACTCCCGGCCTGGAACGAGGCGTTGGGACTGCCCCGCCCCTGGGACCAGCAGTGGTCCCTGCGCATCCAGCAGGTCCTCGCGCACGAGAGCGACCTCCTGGAGTACGAGGACATCTTCGCGGGCTCGCACGTCATCGAGAAGAAGGTCGACGAGCTGGTCACCGACTCGCTCACCGAGATGGACCGGATCCAGGAGATGGGCGGCGCGATGGCCGCCGTCGAGTCCGGCTACCTCAAGTCCCAGCTCGTCTCCTCGCACGCCGAGCGCAGGGCCAGGATCGAGGCGGGCCACGAGAAGATCGTCGGCGTGAACGTGTACGAGTCGACCGAGACCAACCCTCTCACCGCCGACCTGGACGCCGCGATCATGACGGTGGACCACGCCGTCGAGGCGAAGGTCGTGCGGGCCATCGGCGACTGGCGCACCACGCGTCAGGAGTCCTCGGACCGCCAGGGCATGGGCGACCCGTTCCACTACCCGACCACGGGGCAGGCCCTGGAGCGCCTCAAGGAGGCGGCCGCGGGTACGGAGAACCTCATGGAGGCCACCCTGGAGTGCGCCCGCGCCGGGGTCACGACCGGCGAGTGGTCAGGGGCCCTGCGCGAGGTGTTCGGCGAGTTCCGGGCCCCCACCGGAGTCTCGTCGGCGCCGGTCGCGGTGGCCGCGGAGGAGGGCTCGCCGATGGCCGAGGTCCGCCGCAAGGTCGCCCTGACCGGCGAGGAACTCGGCGGCAAGCTCCGCCTCCTTGTCGGCAAGCCGGGCCTGGACGGCCACTCCAACGGCGCCGAGCAGATCGCCGTGCGCGCCCGCGACGCCGGGTTCGAGGTGGTCTACCAGGGCATCCGGCTCACCCCGGAACAGATCGTGTCCGCCGCGCTCGCCGAGGACGTGCACTGCGTCGGCCTGTCGATCCTCTCCGGGTCACACGCCGAGCTGGTGCCCGACGTCCTCGTCCGGATGCGCGAGGCGGGCGCCACCGACGTCCCCGTGATCGTCGGTGGCATCATCCCCAACGCCGACGCCGAGGACTTGAAGCGTGCGGGTGTGGCCGCCGTGTTCACGCCCAAGGACTTCGGCATCACGGAGATCATCGGCCGTATCGTCGACGAGATCCGGAAAGCGAACAAGCTCGACCCTCTGGAGGTCCCCGCATGA	MTERQKDRPWLMRTYAGHSTAEASNELYRRNLAKGQTGLSVAFDLPTQTGYDPDHILARGEVGRVGVPVSHLGDMRRLFQDIPLDRMNTSMTINATAMWLLALYQVVAEEQGADITQLQGTTQNDIVKEYLSRGTHVFPPGPSLRLTTDMITYTVAHIPKWNPINICSYHLQEAGATPVQEIAYAMSTAIAVLDAVRDSGQVPEEKFGDVVARISFFVNAGVRFIEEMCKMRAFGRIWDQITRERYGIENPKQRRFRYGVQVNSLGLTEAQPENNVQRIVLEMLAVTLSKDARARAVQLPAWNEALGLPRPWDQQWSLRIQQVLAHESDLLEYEDIFAGSHVIEKKVDELVTDSLTEMDRIQEMGGAMAAVESGYLKSQLVSSHAERRARIEAGHEKIVGVNVYESTETNPLTADLDAAIMTVDHAVEAKVVRAIGDWRTTRQESSDRQGMGDPFHYPTTGQALERLKEAAAGTENLMEATLECARAGVTTGEWSGALREVFGEFRAPTGVSSAPVAVAAEEGSPMAEVRRKVALTGEELGGKLRLLVGKPGLDGHSNGAEQIAVRARDAGFEVVYQGIRLTPEQIVSAALAEDVHCVGLSILSGSHAELVPDVLVRMREAGATDVPVIVGGIIPNADAEDLKRAGVAAVFTPKDFGITEIIGRIVDEIRKANKLDPLEVPA	MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTFKIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIGIKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVKEMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKVFALNLDIDKFEDLYKREKILEKYLDELVKKS	269.57	gnl|BL_ORD_ID|3859|hsp_num:0	4929			660	759	cloxacillin; oxacillin; cefalotin
BGC0000706.1|Kanamycin_10 # 10548 # 11513 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.675	BGC0000706.1|Kanamycin_10 	10548	11513	+	Loose	400	26.5646	CRP	31.71	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGCGCCCATCAACCGTCTCCGTCCCCGCCGCTCGTGTCTGGCGGTCCCGGGTTCGAACCCGCGCTTCCTGGAGAAGGCCCAGGGTCTGCCCGCGGACCAGGTCTTCCTGGACCTGGAGGACGCCTGCGCGCCGCTCGCCAAGCCGGAGGCCCGGCACACCATCGTGAAGTTCCTCAACGAGGGCGACTGGACGGGCAAGACGCGGGTGGTGCGCGTCAACGACTGGACCACCGAGTGGACGTACCGCGACGTCGTCACGGTCGTCGAGGGCGCGGGCCAGAACCTCGACTGCATCATGCTGCCGAAGGTGCAGACGGCCGACCAGGTCGTCGCGCTCGACCTGCTCCTGACCCAGATCGAGAAGACCATGGGCTTCGAGGTCGGCAAGATCGGCATCGAGGCGCAGATCGAGAACGCCCAGGGCCTCAACAACGTCAACGCGATCGCCGAGGCGTCCCAGCGCGTCGAGACGATCATCTTCGGCCCGGCCGACTTCATGGCGTCGATCAACATGAAGTCCCTGGTCGTCGGCGAGCAGCCGCCCGGGTACCCGGCCGACGCCTACCACTTCATCCTGATGAAGATCCTGATGGCCGCCCGTGCCAACAACCTCCAGGCGATCGACGGCCCCTACCTCCAGATCAAGAACGTCGACGGCTACCGCGAGGTCGCGAACCGCGCCGCGGCGCTCGGCTTCGACGGCAAGTGGGTCCTGCACCCCGGCCAGGTCGAGGCGGCCAACGAGGTCTTCTCGCCCTCGCAGGAGGACTTCGACCACGCCGAGCTGATCCTGGACGCGTACGAGTACTACACGTCCGAGGCGGGCGGAAAGAAGGGCTCGGCGATGCTCGGCGACGAGATGATCGACGAGGCGAGCCGGAAGATGGCGCTCGTCATCTCCGGGAAGGGCCGTGCGGCGGGTATGCAGCGCACGTCCACGTTCGAGGCCCCGGAGGCGTAA	MTAPINRLRPRRSCLAVPGSNPRFLEKAQGLPADQVFLDLEDACAPLAKPEARHTIVKFLNEGDWTGKTRVVRVNDWTTEWTYRDVVTVVEGAGQNLDCIMLPKVQTADQVVALDLLLTQIEKTMGFEVGKIGIEAQIENAQGLNNVNAIAEASQRVETIIFGPADFMASINMKSLVVGEQPPGYPADAYHFILMKILMAARANNLQAIDGPYLQIKNVDGYREVANRAAALGFDGKWVLHPGQVEAANEVFSPSQEDFDHAELILDAYEYYTSEAGGKKGSAMLGDEMIDEASRKMALVISGKGRAAGMQRTSTFEAPEA	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	152.86	gnl|BL_ORD_ID|803|hsp_num:0	869			96	219	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000706.1|Kanamycin_11 # 11518 # 12030 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.622	BGC0000706.1|Kanamycin_11 	11518	12030	+	Loose	200	29.261	dfrL	27.38	3007456	protein homolog model	n/a	n/a	aminoglycoside antibiotic; tetracycline antibiotic; diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCAGTTCGGCCGCACCTACGAAGAGTTCGAAGTCGGCGCCGTGTACAAGCACTGGCCCGGAAAAACGGTCACCGAGTACGACGACCACCTCTTCTGTCTCCTGACCATGAACCACCACCCCCTCCACATGGACAACAACTATGCGGAGAAGACGACGGACTTCGGGAAGAACGTCGTCGTGGGCAATTACATCTACTCGCTGCTGCTCGGCATGTCGGTCCCCGACGTCTCCGGCAAGGCCATCGCCAACCTGGAGGTCGAATCGCTCAAGCACGTGGCGCCGACCTTCCACGGCGACACGATCTACGGCGAGACGACGGTCCTCGACAAGACGCCTTCGAAGTCCAAGAGCGACCGCGGGATCGTCTACGTGGAGACCAAGGGCTACAAGCAGGACGGCACGCTGGTCTGCGTGTTCCGCCGCAAGGTGATGGTGCCCACCGAGACGTACATCAAGGAGCGCGGCGGCGAGCAGCCCGGCCGCCCGGAGCTCAAGAGCCAGGAGAAGTAG	MQFGRTYEEFEVGAVYKHWPGKTVTEYDDHLFCLLTMNHHPLHMDNNYAEKTTDFGKNVVVGNYIYSLLLGMSVPDVSGKAIANLEVESLKHVAPTFHGDTIYGETTVLDKTPSKSKSDRGIVYVETKGYKQDGTLVCVFRRKVMVPTETYIKERGGEQPGRPELKSQEK	MGENIEGRCCQELRKPYMTFVWAEDSNGLIGSSGDLPWNLPLDMKHFKNVTMDDVVVMGRKTYESIPVRPLKNRINIVLTNNKSYVADGAIVCHSKEDVLNYLKENKIEKPIHVIGGISAFEMFKDEVNILHRTIIDETFEGDTYMPEIDYKYFRCIDIADGVVDEKNKYPHRFLVYERKKFIDLMDYGGLLE	88.08	gnl|BL_ORD_ID|4955|hsp_num:0	5947			96	333	streptomycin; tetracycline; tobramycin; trimethoprim; iclaprim
BGC0000706.1|Kanamycin_12 # 12033 # 13238 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.622	BGC0000706.1|Kanamycin_12 	12033	13238	+	Loose	1000	28.8758	tet(43)	24.64	3000573	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCGACTCGCCCAGACCGCGGGGTTGACGGACATCCAGCAGGAGATCCTGTCCACCGTCCGTGACTTCGTCGACAAGGAGATCATTCCGGTCGCGACGGAACTCGAGCACCGTGACGAGTACCCGCAGCAGATCGTGGACGGCCTCAAGGAGTTGGGCCTGTTCGGGCTCATGATCCCTGAGGAGTACGGCGGCCTCGGCGAGTCGCTGCTCACCTACGCGCTGTGCGTCGAGGAGATAGCGCGCGGCTGGATGTCGGTGTCCGGCATCATCAACACCCACTTCATCGTGGCCTACATGCTCAAGCAGCACGGCACGCAGGAGCAGAAGGAGACGTTCCTGCCTCGCATGGCGGCGGGCGAGGTGCGCGGCGCGTTCTCCATGTCGGAGCCGGGACTCGGCTCAGATGTGTCGGCCATCACGTCGAAGGGCGTCAAGGACGGGGACGACTACGTCCTCAACGGCCAGAAGATGTGGTTGACGAACGGCGGCACGTCCACTTTGGTGGCCGTCCTGTGCCGAAGTGACGAAGGACACCCCGAGGGCACGGCGCCCCACAAGTCGATGACCACGTTCCTTGTCGAGAAGGAGCCCGGTTTCGGAGAGGTCCGGCCGGGCCTCACCATCCCCGGCAAGATCGACAAGATGGGTTACAAGGGCGTCGACACCACCGAACTCATCATGGACGGGCTACGCATTCCGGCCAATCGTGTGCTCGGCGGGGCCACCGGCCGAGGGTTTTACCAAATGATGGACGGCGTCGAAGTCGGCCGCGTCAATGTGGCGGCGCGTGGTTGCGGCGTCGCACAGCGTGCATTTGAGCTCGGTGTCTCTTATGCCCAGCAACGCCACACTTTCGGCAAGCCGATCGCCCAGCATCAGGCGATTCAGTTCAAGCTGGCGGAGATGGCTACCAAGGTCGAGGCCGCCCATGCGATGATGGTCAATGCCGCACGCAAAAAGGACTCCGGGGAGCGAAACGACCTCGAAGCAGGGATGGCGAAGTACCTCGCCTCCGAGTACTGCAAGGAAGTCGTGGAGGACGCGTTCAGGATTCACGGCGGTTACGGCTTCTCGAAGGAGTACGAGATCGAGCGCCTCTACAGGGAGGCTCCGATGCTGTTGATCGGTGAAGGTACCGCCGAGATCCAGAAAATGATCATTGGTCGTCGACTGCTCGAAGAGTATCGATTCCAGGGCTAG	MSRLAQTAGLTDIQQEILSTVRDFVDKEIIPVATELEHRDEYPQQIVDGLKELGLFGLMIPEEYGGLGESLLTYALCVEEIARGWMSVSGIINTHFIVAYMLKQHGTQEQKETFLPRMAAGEVRGAFSMSEPGLGSDVSAITSKGVKDGDDYVLNGQKMWLTNGGTSTLVAVLCRSDEGHPEGTAPHKSMTTFLVEKEPGFGEVRPGLTIPGKIDKMGYKGVDTTELIMDGLRIPANRVLGGATGRGFYQMMDGVEVGRVNVAARGCGVAQRAFELGVSYAQQRHTFGKPIAQHQAIQFKLAEMATKVEAAHAMMVNAARKKDSGERNDLEAGMAKYLASEYCKEVVEDAFRIHGGYGFSKEYEIERLYREAPMLLIGEGTAEIQKMIIGRRLLEEYRFQG	MPPSHHMLRPIEQCSILWNDVRYSNSVRLKEAGMTATTQASAPAARTYLSLRAAWIPLFALCLAFFVEMVDNTLLTIALPTIGRDLGASVTSLQWVTGAYSLTFGGLLLTAGSLADRFGRRRVLQIGLLAFGLISLTVIAVATAGQLIAVRAALGLAAAAMAPITNSLVFRLFEGEDLRRRAMTLMIVVGMSGFILGPLLGGTVLAHASWQWLLLINAPIALIALIGVRLGVPADDAEGLTKDRLDVKGSALSIAAIGLACYTLTSGVEHGWMSAVTWACGIGAAAALMGFVWHERRTDHPMLDLDVFRNRTVRGASIAQVGTSIAMASLMFGLILHFQGAYGWSPMRAGLANLPLILTMILATPVSEGLAKRFGHRIAMLIGAGLLAGSLAGLAWGVGHGYLVIAVFMVTFTLGLRTVMTIAAVGLVGAMPENRTSLGAALNDTAQEVGTSLGMAVIGTLIAVLXTTTLPNGDXSLDLATSYFAGERIAYLFLAVVVGVIAGWGALTLSNSKEMEDVH	77.26	gnl|BL_ORD_ID|1634|hsp_num:0	1773			684	891	tetracycline
BGC0000706.1|Kanamycin_13 # 13409 # 14065 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.697	BGC0000706.1|Kanamycin_13 	13409	14065	+	Loose	2030	25.0238	ceoB	57.89	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCCACAGCCAAACCTCTGCACCACGCGACGGCATTCTTCAGGGACGCCTTGCTCGCGGAGCATCGCCGTGGCTCCTGCCGACCGTCGCCACCGCGGCACTCAGCCTCGCCCGCGCGCGCCGCTCCAAGGGCGCCGCGGCCGTCGCCGTGCCCGCCACCGCGCTGGCGGCGGGCATGCTGTGGTTCTTCCGCGACCCCGAGCGCGAGATCGCCCAGGGCCGGGTCATCTCTCCCGCCGACGGCGTGGTGCAGAGCATCATGCCGTGGAAGGACGGGCGCACCCGCGTCGCCATCTTCATGAGCCCGCTGAACGTCCACGTCAACCGCGCGCCCCTCGCGGGCACGGTGACGTCCGTGGAGCACATCCCCGGCGGGTTCGTCCCGGCGTTCAACAAGGAGAGCGAGAACAACGAGCGCGTTGTCTGGCACTTCGACACCGAGCTCGGCGACATCGAGATGATCCAGATCGCGGGCGCGGTCGCGCGACGCATCGTGCCCTACGTGCCGCAGGGATCGAAGGTGGAGCAGGGCGAGCGGATCGGCCTGATCCGCTTCGGCTCCCGCGTCGACATCTACCTCCCCGAGGGTGTCGAGGTGGACGTCGAGGTCGGTCAGAAGACCGTGGCTGGGGTGACTCGCATTGACCGTGGTTGA	MPHSQTSAPRDGILQGRLARGASPWLLPTVATAALSLARARRSKGAAAVAVPATALAAGMLWFFRDPEREIAQGRVISPADGVVQSIMPWKDGRTRVAIFMSPLNVHVNRAPLAGTVTSVEHIPGGFVPAFNKESENNERVVWHFDTELGDIEMIQIAGAVARRIVPYVPQGSKVEQGERIGLIRFGSRVDIYLPEGVEVDVEVGQKTVAGVTRIDRG	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	21.23	gnl|BL_ORD_ID|1148|hsp_num:0	1252			1677	1734	
